Jelle C L Himmelreich
Overview
Explore the profile of Jelle C L Himmelreich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Himmelreich J, Virdone S, Camm A, Pieper K, Harskamp R, Verheugt F, et al.
Open Heart
. 2025 Jan;
12(1.
PMID: 39832940
Aims: This study aimed to determine the robustness, reproducibility and representativeness of the landmark Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (AF) (ARISTOTLE) and Rivaroxaban...
2.
Brik T, Harskamp R, Himmelreich J
Eur Heart J Suppl
. 2024 Aug;
26(Suppl 4):iv12-iv18.
PMID: 39099572
Atrial fibrillation (AF) is a common arrhythmia associated with an increased risk of stroke, which can be effectively reduced by prophylaxis initiation and integrated care to reduce cardiovascular risk and...
3.
Himmelreich J, Virdone S, Camm J, Pieper K, Harskamp R, Oto A, et al.
Open Heart
. 2024 Jul;
11(2).
PMID: 38955399
Background: The extent to which differences in results from Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) and Rivaroxaban Once Daily Oral Direct Factor Xa...
4.
Manten A, Harskamp R, Busschers W, Moll van Charante E, Himmelreich J
Fam Pract
. 2024 May;
41(5):832-840.
PMID: 38801727
Introduction: Telephone triage is pivotal for evaluating the urgency of patient care, and in the Netherlands, the Netherlands Triage Standard (NTS) demonstrates moderate discrimination for chest pain. To address this,...
5.
De Clercq L, Himmelreich J, Harskamp R
Diagnosis (Berl)
. 2024 May;
11(4):380-388.
PMID: 38741552
Objectives: Proper coding of heart failure (HF) in electronic health records (EHRs) is an important prerequisite for adequate care and research towards this vulnerable patient population. We set out to...
6.
Karregat E, de Koning M, Himmelreich J, Koetsier D, de Jong J, Moll van Charante E, et al.
Prim Health Care Res Dev
. 2024 Apr;
25:e18.
PMID: 38634311
Aim: To evaluate the use of a single-lead electrocardiography (1L-ECG) device and digital cardiologist consultation platform in diagnosing arrhythmias among general practitioners (GPs). Background: Handheld 1L-ECG offers a user-friendly alternative...
7.
Harms P, Himmelreich J, Blom M, Beulens J, Nijpels G, Elders P, et al.
Am Heart J Plus
. 2024 Mar;
34:100321.
PMID: 38510951
Background: Premature atrial contractions (PACs) are potential markers for imminent onset of both atrial fibrillation (AF) and brain ischemia (BI; transient ischemic attack [TIA] or ischemic stroke). We investigated the...
8.
Harskamp R, Melessen I, Manten A, De Clercq L, den Elzen W, Himmelreich J
Diagnosis (Berl)
. 2024 Jan;
11(2):171-177.
PMID: 38281102
Objectives: Troponin testing is indicated in the diagnostic work-up of acute coronary syndrome (ACS) and incorporated in risk stratification pathways. This study aims to gain insights on the use, outcomes,...
9.
Harskamp R, De Clercq L, Veelers L, Schut M, van Weert H, Handoko M, et al.
Diagnosis (Berl)
. 2023 Sep;
10(4):432-439.
PMID: 37667563
Objectives: Heart failure (HF) is a prevalent syndrome with considerable disease burden, healthcare utilization and costs. Timely diagnosis is essential to improve outcomes. This study aimed to compare the diagnostic...
10.
Barco S, Virdone S, Gotschi A, Ageno W, Arcelus J, Bingisser R, et al.
Thromb Res
. 2023 Aug;
230:27-32.
PMID: 37625200
Background: Antithrombotic treatment may improve the disease course in non-critically ill, symptomatic COVID-19 outpatients. Methods: We performed an individual patient-level analysis of the OVID and ETHIC randomized controlled trials, which...